The table below shows the Pharma Mutual Funds based on AUM, NAV, and minimum SIP.
| Name | AUM (Cr) | Minimum SIP (Rs) | NAV (Rs) |
| Nippon India Pharma Fund | 6470.4 | 100.0 | 447.23 |
| ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund | 3279.62 | 5000.0 | 29.86 |
| SBI Healthcare Opp Fund | 2263.22 | 5000.0 | 360.7 |
| DSP Healthcare Fund | 2023.0 | 100.0 | 33.13 |
| Mirae Asset Healthcare Fund | 1974.05 | 100.0 | 31.92 |
| UTI Healthcare Fund | 870.48 | 1500.0 | 234.97 |
| Tata India Pharma & Healthcare Fund | 759.57 | 1500.0 | 26.62 |
| HDFC Pharma and Healthcare Fund | 591.75 | 100.0 | 11.73 |
| Aditya Birla SL Pharma & Healthcare Fund | 565.11 | 100.0 | 26.61 |
| Kotak Healthcare Fund | 214.38 | 100.0 | 10.5 |
Pharma Mutual Funds are investment funds that primarily allocate their assets to pharmaceutical and healthcare companies’ stocks and bonds, seeking to profit from the pharmaceutical industry’s performance.
Content:
- Best Pharma Mutual Funds
- Best Pharma Fund
- Top Mutual Funds In Pharma Sector
- Top Pharmaceutical Mutual FundsÂ
- Top Pharma Mutual Funds
- Pharma Mutual Funds – FAQ
- Introduction to Pharma Mutual Funds
Best Pharma Mutual Funds
The table below shows the Best Pharma Mutual Funds based on the lowest to highest expense ratio.
| Name | Expense Ratio % |
| Kotak Healthcare Fund | 0.0 |
| ITI Pharma & Healthcare Fund | 0.43 |
| Mirae Asset Healthcare Fund | 0.54 |
| DSP Healthcare Fund | 0.69 |
| Quant Healthcare Fund | 0.77 |
| Tata India Pharma & Healthcare Fund | 0.9 |
| Nippon India Pharma Fund | 0.94 |
| SBI Healthcare Opp Fund | 1.0 |
| Aditya Birla SL Pharma & Healthcare Fund | 1.06 |
| ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund | 1.12 |
Best Pharma Fund
The table below shows the Best Pharma Fund Based on the Highest 5Y CAGR.
| Name | CAGR 5Y (Cr) |
| DSP Healthcare Fund | 26.77 |
| Mirae Asset Healthcare Fund | 25.18 |
| ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund | 24.68 |
| Tata India Pharma & Healthcare Fund | 23.75 |
| Nippon India Pharma Fund | 23.21 |
| SBI Healthcare Opp Fund | 22.83 |
| UTI Healthcare Fund | 21.7 |
| Quant Healthcare Fund | 0.0 |
| LIC MF Healthcare Fund | 0.0 |
| HDFC Pharma and Healthcare Fund | 0.0 |
Top Mutual Funds In Pharma Sector
The table below shows Top Mutual Funds In the Pharma Sector based On exit load i.e., the fee that the AMC charges investors when exiting or redeeming their fund units.
| Name | Exit Load % |
| Tata India Pharma & Healthcare Fund | 0.25 |
| SBI Healthcare Opp Fund | 0.5 |
| DSP Healthcare Fund | 0.5 |
| ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund | 1.0 |
| UTI Healthcare Fund | 1.0 |
| Quant Healthcare Fund | 1.0 |
| LIC MF Healthcare Fund | 1.0 |
| Nippon India Pharma Fund | 1.0 |
| Mirae Asset Healthcare Fund | 1.0 |
| HDFC Pharma and Healthcare Fund | 1.0 |
Top Pharmaceutical Mutual Funds
The table below shows Top Pharmaceutical Mutual Funds based on Absolute 1 Year Return and AMC.
| Name | Absolute Returns – 1Y % |
| ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund | 47.02 |
| Aditya Birla SL Pharma & Healthcare Fund | 46.21 |
| SBI Healthcare Opp Fund | 45.34 |
| Nippon India Pharma Fund | 45.1 |
| UTI Healthcare Fund | 43.76 |
| Tata India Pharma & Healthcare Fund | 42.38 |
| DSP Healthcare Fund | 41.34 |
| Mirae Asset Healthcare Fund | 39.53 |
| ITI Pharma & Healthcare Fund | 38.19 |
| LIC MF Healthcare Fund | 32.42 |
Top Pharma Mutual Funds
The table below shows the Top Pharma Mutual Funds List based on Absolute 6-month Return and AMC.
| Name | Absolute Returns – 6M % |
| Quant Healthcare Fund | 31.9 |
| Aditya Birla SL Pharma & Healthcare Fund | 27.2 |
| ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund | 25.89 |
| UTI Healthcare Fund | 25.78 |
| Tata India Pharma & Healthcare Fund | 25.58 |
| DSP Healthcare Fund | 24.86 |
| Nippon India Pharma Fund | 24.66 |
| Mirae Asset Healthcare Fund | 22.92 |
| ITI Pharma & Healthcare Fund | 22.82 |
| LIC MF Healthcare Fund | 21.36 |
Looking for the Best Stocks in different sectors? Check out the following articles:
Pharma Mutual Funds – FAQ
What are the Best Pharma Mutual Funds?
Best Pharma Mutual Funds #1: Nippon India Pharma Fund
Best Pharma Mutual Funds #2: ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund
Best Pharma Mutual Funds #3: SBI Healthcare Opp Fund
Best Pharma Mutual Funds #4: DSP Healthcare Fund
Best Pharma Mutual Funds #5: Mirae Asset Healthcare Fund
These funds are listed based on the Highest AUM.
What are the Top Mutual Funds In the Pharma Sector?
The top 5 Pharma Sector Mutual Funds, determined by their 5-year Compound Annual Growth Rate (CSGR), include DSP Healthcare Fund, Mirae Asset Healthcare Fund, ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund, Tata India Pharma & Healthcare Fund, and Nippon India Pharma Fund.
Is pharma mutual funds good to invest in?
Pharma mutual funds can be a good investment choice for diversification and potential growth, as the pharmaceutical sector often offers stability and growth prospects.
Introduction to Pharma Mutual Funds
Pharma Mutual Funds – AUM, NAV
Nippon India Pharma Fund
The Nippon India Pharma Fund-Growth Plan-Growth Option is an investment scheme offered by Nippon Mutual Fund and belongs to the Pharma & Healthcare category. It was introduced on June 1, 2004.
The investment scheme imposes a 1.0% exit load and maintains an expense ratio of 0.94%. It’s crucial to emphasize that this fund carries a very high level of risk. Nonetheless, it has displayed strong performance over the past 3 years, achieving a Compound Annual Growth Rate (CAGR) of 23.21%. Additionally, the fund manages a substantial amount of assets, with its Assets Under Management (AUM) totaling ₹ 6,470.4 crore.
The shareholding pattern indicates that 1.46% of the holdings are in cash and equivalents, while 98.54% are invested in equity.
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund
The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund – Cumulative Option is an investment scheme offered by ICICI Mutual Fund and is categorized under the Pharma & Healthcare sector. It was introduced on July 25, 2018.
The investment scheme imposes a 1.0% exit load and maintains an expense ratio of 1.12%. It’s essential to highlight that this fund carries a very high level of risk. Nonetheless, it has displayed strong performance over the past 3 years, achieving a Compound Annual Growth Rate (CAGR) of 24.68%. Additionally, the fund manages a substantial amount of assets, with its Assets Under Management (AUM) totaling ₹ 3,279.62 crore.
The shareholding distribution reveals that 0.06% of holdings are in Futures & Options, 0.59% are in Treasury Bills, 3.45% are in Cash & Equivalents, and the majority, which is 96.02%, is invested in equity.
SBI Healthcare Opp Fund
The SBI Healthcare Opportunities Fund – Regular Plan – Growth is an investment scheme offered by SBI Mutual Fund and is categorized under the Pharma & Healthcare sector. It was introduced on July 14, 1999.
The investment scheme imposes a 0.5% exit load and maintains an expense ratio of 1.0%. It’s essential to highlight that this fund carries a very high level of risk. Nonetheless, it has displayed strong performance over the past 3 years, achieving a Compound Annual Growth Rate (CAGR) of 22.83%. Additionally, the fund manages a substantial amount of assets, with its Assets Under Management (AUM) totaling ₹ 2,263.22 crore.
The shareholding pattern indicates that 0.30% of the holdings consist of preference shares, 1.62% are in cash and equivalents, and the majority, 98.07%, is in the form of equity.
Best Pharma Mutual Funds – Expense Ratio
Kotak Healthcare Fund
The Kotak Healthcare Fund Direct-Growth is an equity mutual fund offered by Kotak Mahindra Mutual Fund. It is overseen by its fund managers, Abhishek Bisen, Shibani Kurian, and Dhananjay Tikariha.
The Kotak Healthcare Fund has a 1.0% exit load and a zero expense ratio. It’s important to emphasize that this fund entails a very high level of risk. However, its performance data for the past 5 years, including its Compound Annual Growth Rate (CAGR), and its Assets Under Management (AUM), amounting to ₹ 214.38 crore. The shareholding pattern indicates that 35.03% of the holdings consist of cash and equivalents, while the remaining 64.97% are in the form of equity.
ITI Pharma & Healthcare Fund
The ITI Pharma and Healthcare Fund Direct-Growth is an equity mutual fund offered by ITI Mutual Fund, and it is presently overseen by its fund managers, Dhimant Shah and Rohan Korde.
The ITI Pharma & Healthcare Fund imposes a 1.0% exit load and maintains an expense ratio of 0.43%. It’s noteworthy that this fund carries a very high level of risk. However, specific performance data for the past 5 years, including Compound Annual Growth Rate (CAGR), is not available, and the fund manages assets totaling ₹ 143.28 crore.
The shareholding distribution indicates that 2.24% of the holdings are cash and equivalents, while the remaining 97.76% is equity.
Mirae Asset Healthcare Fund
The Mirae Asset Healthcare Fund Direct-Growth is an equity mutual fund offered by Mirae Asset Mutual Fund, and it is presently overseen by its fund manager, Vrijesh Kasera.
The investment scheme imposes a 1.0% exit load and maintains an expense ratio of 0.54%. It’s essential to highlight that this fund carries a very high level of risk. Nevertheless, it has displayed strong performance over the past 5 years, achieving a Compound Annual Growth Rate (CAGR) of 25.18%. Additionally, the fund manages a substantial amount of assets, with its Assets Under Management (AUM) totaling ₹ 1,974.05 crore.
The shareholding pattern indicates that mutual funds account for 0.01% of the holdings, while cash and equivalents make up 1.91%, with the majority, 98.08%, invested in equity.
Best Pharma Fund- 5Y CAGR
DSP Healthcare Fund
The DSP Healthcare Fund – Regular Plan – Growth is an investment scheme offered by DSP Mutual Fund and belongs to the Pharma & Healthcare category. It was introduced on November 5, 2018.
The investment scheme imposes a 0.5% exit load and maintains an expense ratio of 0.69%. It’s crucial to highlight that this fund carries a very high level of risk. Nonetheless, it has demonstrated strong performance over the past 5 years, achieving a Compound Annual Growth Rate (CAGR) of 26.77%. Additionally, the fund manages a substantial amount of assets, with its Assets Under Management (AUM) totaling ₹ 2,023.0 crore.
The shareholding breakdown shows that 0.86% of the holdings are in cash and equivalents, 1.23% are in mutual funds, and the majority, 97.92%, is invested in equity.
Tata India Pharma & Healthcare Fund
The Tata India Pharma & HealthCare Fund Direct-Growth is an equity mutual fund offered by Tata Mutual Fund, and it is currently overseen by its fund manager, Meeta Shetty.
The Tata India Pharma & Healthcare Fund has a 0.25% exit load and an expense ratio of 0.9%. It’s important to note that this fund carries a very high level of risk. However, it has shown strong performance over the past 5 years, achieving a Compound Annual Growth Rate (CAGR) of 23.75%. Additionally, the fund manages a substantial amount of assets, with its Assets Under Management (AUM) totaling ₹ 759.57 crore.
The shareholding distribution indicates that 2.03% of the holdings are in cash and equivalents, while the remaining 97.97% are in equity.
UTI Healthcare Fund
The UTI Healthcare Fund Direct-Growth is an equity mutual fund scheme offered by UTI Mutual Fund and is presently overseen by its fund manager, Kamal Gada.
The investment scheme imposes a 1.0% exit load and maintains an expense ratio of 1.36%. It’s crucial to note that this fund carries a very high level of risk. Nevertheless, it has shown strong performance over the past 5 years, achieving a Compound Annual Growth Rate (CAGR) of 21.7%. Additionally, the fund manages a substantial amount of assets, with its Assets Under Management (AUM) totaling ₹ 870.48 crore.
The distribution of holdings reveals that 0.15% is invested in Treasury Bills, 1.36% in cash and equivalents, and the majority, 98.50%, is allocated to equity.
Top Mutual Funds In Pharma Sector – Exit Load
Quant Healthcare Fund
The Quant Healthcare Fund Regular – Growth is an investment scheme offered by Quant Mutual Fund, and it is categorized under the Pharma & Healthcare sector. It was introduced on July 11, 2023.
The investment scheme imposes a 1.0% exit load and maintains an expense ratio of 0.77%. It’s essential to note that this fund carries a very high level of risk. Nevertheless, it manages a substantial amount of assets, with its Assets Under Management (AUM) totaling ₹ 191.65 crore.
The distribution of holdings indicates that 2.57% consists of Treasury Bills, 3.70% is in cash and equivalents, 15.74% is in Futures & Options, and the majority, 77.98%, is in equity.
LIC MF Healthcare Fund
The LIC MF Healthcare Fund Direct-Growth is an equity mutual fund offered by LIC Mutual Fund and is presently overseen by its fund manager, Karan Doshi.
The investment scheme imposes a 1.0% exit load and maintains an expense ratio of 1.21%. It’s important to highlight that this fund carries a very high level of risk. The fund manages a relatively lower amount of assets, with its Assets Under Management (AUM) totaling ₹ 53.84 crore. The distribution of holdings indicates that 2.86% of the portfolio consists of cash and equivalents, while the remaining 97.14% is invested in equity.
HDFC Pharma and Healthcare Fund
The HDFC Pharma And Healthcare Fund Direct-Growth is an equity mutual fund offered by HDFC Mutual Fund and is presently overseen by its fund manager, Nikhil Mathur.
The investment scheme imposes a 1.0% exit load and maintains an expense ratio of 1.2%. It’s crucial to note that this fund carries a very high level of risk. The fund manages assets totaling ₹ 591.75 crore.
The shareholding composition indicates that 1.33% of the holdings are cash and equivalents, while the remaining 98.67% are in equity.
Top Pharmaceutical Mutual Funds – Absolute 1 Year Return
Aditya Birla SL Pharma & Healthcare Fund
The Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth is an equity mutual fund offered by Aditya Birla Sun Life Mutual Fund.
The investment scheme imposes a 1.0% exit load and maintains an expense ratio of 1.06%. It’s important to note that this fund carries a very high level of risk. However, it has shown strong absolute returns over the past year, with a growth rate of 46.21%. Additionally, the fund manages a substantial amount of assets, with its Assets Under Management (AUM) totaling ₹ 565.11 crore.
The shareholding distribution indicates that 4.41% of the holdings are in cash and equivalents, while the remaining 95.59% are in equity.
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change over time.
We hope you’re clear on the topic, but there’s more to explore in stocks, commodities, mutual funds, and related areas. Here are important topics to learn about.
